Wexford Capital »

Legend Biotech 2 Adr Rep Ord shares owned by Wexford Capital

Quarter-by-quarter ownership of Legend Biotech 2 Adr Rep Ord (LEGN) shares owned by Wexford Capital from 13F filings

Historical chart of Wexford Capital investment in Legend Biotech 2 Adr Rep Ord

Tip: Access up to 7 years of quarterly data

All positions including Legend Biotech 2 Adr Rep Ord held by Wexford Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Legend Biotech 2 Adr Rep Ord by Wexford Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $425k 7.1k 60.17
2023-09-30 $949k 14k 67.17
2023-06-30 $975k 14k 69.03

More positions owned by Wexford Capital

Mammoth Energy Svcs (TUSK)
International Seaways (INSW)
Nephros (NEPH)
Ishares Msci Aust Etf (EWA)
Ishares Msci Cda Etf (EWC)
Spdr Ser Tr Portfolio S&p600 (SPSM)
Cenovus Energy (CVE)
Stellantis SHS (STLA)
Cool Common Shares (CLCO)
Astrazeneca Sponsored Adr (AZN)
Silverbow Resources (SBOW)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Gold Tr Gold Shs (GLD)
Golar Lng SHS (GLNG)
Enterprise Products Partners (EPD)

View all positions for Wexford Capital

Top funds holding Legend Biotech 2 Adr Rep Ord

T. Rowe Price Associates
RA Capital Management
Hillhouse Capital Advisors
Wellington Management Company
Massachusetts Financial Services
Paradigm Biocapital Advisors
Henderson Group
Westfield Capital Management Company
Holocene Advisors
Federated Investors
Alliancebernstein
TimesSquare Capital Management
Arrowpoint Asset Management
Matthews International Capital Management
Avidity Partners Management

View all funds holding Legend Biotech 2 Adr Rep Ord